SynthesisFrontiers in cardiovascular medicine2022

The Efficacy and Safety of the Combined Therapy of Sodium-Glucose Co-Transporter-2 Inhibitors and Angiotensin Receptor-Neprilysin Inhibitor in Patients With Heart Failure With Reduced Ejection Fraction: A Meta-Analysis of the EMPEROR-Reduced and DAPA-HF Sub-Analysis.

Yanxia Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.